# Drug Policy: Resources

## Overview

This chapter provides a curated guide to the key data sources, research organizations, government reports, advocacy organizations, and academic literature on U.S. drug policy. Resources are organized by category and include brief descriptions of scope and utility.

---

## Government Data Sources

### Federal Agency Data

| Source | Agency | Description | URL |
|--------|--------|-------------|-----|
| CDC WONDER | CDC | Drug overdose death data by substance, state, demographics, year | wonder.cdc.gov |
| National Survey on Drug Use and Health (NSDUH) | SAMHSA | Annual survey of substance use, SUD prevalence, and treatment | samhsa.gov/data/nsduh |
| National Survey of Substance Abuse Treatment Services (N-SSATS) | SAMHSA | Annual census of SUD treatment facilities | samhsa.gov/data/n-ssats |
| Treatment Episode Data Set (TEDS) | SAMHSA | Data on admissions to and discharges from SUD treatment | samhsa.gov/data/teds |
| National Drug Early Warning System (NDEWS) | NIDA | Emerging drug trends, sentinel community surveillance | ndews.org |
| Uniform Crime Reporting (UCR) / NIBRS | FBI | Drug arrest data by offense, demographics, jurisdiction | crime-data-explorer.fr.cloud.gov |
| Federal Drug Seizure Data | DEA | Drug seizures by substance, weight, and location | dea.gov |
| U.S. Sentencing Commission Data | USSC | Federal drug sentencing data, mandatory minimums, demographics | ussc.gov |
| Bureau of Prisons Statistics | BOP | Federal prisoner demographics, offense type | bop.gov |
| National Drug Control Budget | ONDCP | Federal drug spending by category (treatment, prevention, enforcement) | whitehouse.gov/ondcp |

### State and Local Data

| Source | Description |
|--------|-------------|
| State cannabis regulatory agencies | Revenue, licensing, enforcement, and market data by state |
| State prescription drug monitoring programs (PDMPs) | Prescribing data by provider, patient, and pharmacy |
| State vital statistics offices | Overdose death data with greater geographic detail than CDC |
| Bureau of Justice Statistics (BJS) | State prison population data, including drug offenses |

---

## Government Reports and Strategies

### Key Federal Reports

- **National Drug Control Strategy** (ONDCP, annual). The federal government's overarching drug policy framework, including budget priorities and performance metrics. Available at whitehouse.gov/ondcp.
- **National Survey on Drug Use and Health: Annual Report** (SAMHSA, annual). The most comprehensive survey of substance use, mental health, and treatment in the United States. Key source for prevalence data.
- **Drug Enforcement Administration: National Drug Threat Assessment** (DEA, annual). Assessment of illicit drug threats, trafficking patterns, and supply dynamics.
- **CDC Morbidity and Mortality Weekly Report (MMWR): Drug Overdose** (CDC, periodic). Peer-reviewed surveillance reports on overdose deaths, trends, and disparities.
- **Government Accountability Office: Drug Policy Reports** (GAO, periodic). Oversight reports on federal drug programs, spending, and effectiveness.
- **Congressional Research Service: Drug Policy Reports** (CRS, periodic). Nonpartisan policy analyses for Congress on scheduling, cannabis, sentencing, and related topics.
- **U.S. Sentencing Commission: Drug Offense Reports** (USSC, annual). Data on federal drug sentencing, mandatory minimums, racial disparities, and trends.

### Landmark Government Reports

- **Shafer Commission Report**: "Marihuana: A Signal of Misunderstanding" (National Commission on Marihuana and Drug Abuse, 1972). Recommended decriminalization of cannabis; rejected by President Nixon.
- **National Academy of Sciences**: "The Health Effects of Cannabis and Cannabinoids" (NASEM, 2017). Comprehensive review of evidence on cannabis health effects.
- **Surgeon General's Report on Alcohol, Drugs, and Health**: "Facing Addiction in America" (2016). Landmark report calling for a public health approach to addiction.
- **President's Commission on Combating Drug Addiction and the Opioid Crisis** (2017). Bipartisan commission recommendations on opioid crisis response.

---

## Research Organizations and Think Tanks

### Drug Policy Research

| Organization | Focus | Key Publications |
|-------------|-------|-----------------|
| RAND Corporation Drug Policy Research Center | Evidence-based drug policy analysis | Cost-effectiveness studies, international comparisons, cannabis legalization analysis |
| Drug Policy Alliance (DPA) | Comprehensive drug policy reform | State and federal policy analyses, decriminalization advocacy, racial justice reports |
| Cato Institute | Libertarian drug policy | Drug legalization arguments, prohibition failure analysis |
| Brookings Institution | Drug policy and governance | International drug policy, cannabis regulation, sentencing reform |
| R Street Institute | Conservative/libertarian reform | Cannabis policy, criminal justice reform, harm reduction |
| Urban Institute | Drug policy and criminal justice | Sentencing reform, reentry, racial disparities |
| Vera Institute of Justice | Justice reform | Incarceration data, racial disparities, diversion programs |
| The Sentencing Project | Sentencing and incarceration reform | Racial disparities, mandatory minimums, sentencing data |
| National Bureau of Economic Research (NBER) | Economic analysis of drug policy | Cannabis legalization effects, drug markets, treatment economics |

### Public Health Research

| Organization | Focus | Key Publications |
|-------------|-------|-----------------|
| National Institute on Drug Abuse (NIDA) | Addiction research | Drug facts, research reports, clinical trial data |
| Johns Hopkins Center for Psychedelic and Consciousness Research | Psychedelic medicine | Psilocybin clinical trials, policy recommendations |
| MAPS (Multidisciplinary Association for Psychedelic Studies) | Psychedelic therapy | MDMA for PTSD clinical data, regulatory pathway analysis |
| RTI International | Drug use epidemiology | NSDUH methodology, treatment outcomes research |
| Boston University School of Public Health | Harm reduction research | Supervised consumption site evidence, naloxone distribution |
| Columbia University Mailman School of Public Health | Drug policy and epidemiology | Overdose surveillance, cannabis policy effects |

---

## Academic Literature: Key Works

### Books

- Alexander, Michelle. *The New Jim Crow: Mass Incarceration in the Age of Colorblindness*. The New Press, 2010. Foundational analysis of how the War on Drugs has functioned as a system of racial control.
- Hari, Johann. *Chasing the Scream: The Opposite of Addiction Is Connection*. Bloomsbury, 2015. History and critique of drug prohibition from Harry Anslinger to modern harm reduction.
- Macy, Beth. *Dopesick: Dealers, Doctors, and the Drug Company that Addicted America*. Little, Brown and Company, 2018. Investigative account of the opioid epidemic from Purdue Pharma's marketing to its impact on Appalachian communities.
- Keefe, Patrick Radden. *Empire of Pain: The Secret History of the Sackler Dynasty*. Doubleday, 2021. Detailed history of the Sackler family and Purdue Pharma's role in the opioid crisis.
- Hart, Carl. *Drug Use for Grown-Ups: Chasing Liberty in the Land of Fear*. Penguin Press, 2021. Columbia neuroscientist's argument for drug legalization based on evidence and personal liberty.
- Quinones, Sam. *Dreamland: The True Tale of America's Opiate Epidemic*. Bloomsbury, 2015. Dual narrative of black tar heroin distribution and OxyContin marketing.
- Baum, Dan. *Smoke and Mirrors: The War on Drugs and the Politics of Failure*. Little, Brown and Company, 1996. Historical analysis of drug war politics from Nixon through Clinton.
- Courtwright, David T. *Dark Paradise: A History of Opiate Addiction in America*. Harvard University Press, 2001. Scholarly history of American opioid addiction from the 19th century forward.
- Szalavitz, Maia. *Undoing Drugs: The Untold Story of Harm Reduction and the Future of Addiction*. Hachette Go, 2021. History and evidence for harm reduction approaches.
- Nutt, David. *Drugs Without the Hot Air*. UIT Cambridge, 2012. Evidence-based analysis of drug harms by the former UK drug policy adviser.

### Seminal Academic Papers

- Nutt, David J., Leslie A. King, and Lawrence D. Phillips. "Drug Harms in the UK: A Multicriteria Decision Analysis." *The Lancet* 376 (2010): 1558-1565. Evidence-based ranking of drug harms that contradicts current scheduling.
- Porter, Jane, and Hershel Jick. "Addiction Rare in Patients Treated with Narcotics." *New England Journal of Medicine* 302 (1980): 123. The one-paragraph letter misrepresented by Purdue Pharma to market OxyContin.
- Volkow, Nora D., and Thomas R. Koob. "Brain Disease Model of Addiction: Why Is It So Controversial?" *The Lancet Psychiatry* 2 (2015): 677-679. Defense of the brain disease model by the NIDA director.
- RAND Corporation. "Controlling Cocaine: Supply Versus Demand Programs." (Rydell and Everingham, 1994). Landmark study showing treatment is 7 times more cost-effective than enforcement.
- Greenwald, Glenn. "Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies." Cato Institute, 2009. Comprehensive analysis of Portugal's decriminalization model.

---

## Legal Resources

### Key Federal Statutes

| Statute | Citation | Description |
|---------|----------|-------------|
| Controlled Substances Act (1970) | 21 U.S.C. Sections 801-904 | Federal drug scheduling and enforcement framework |
| Anti-Drug Abuse Act (1986) | Pub. L. 99-570 | Mandatory minimums, crack/powder disparity |
| Fair Sentencing Act (2010) | Pub. L. 111-220 | Reduced crack/powder disparity to 18:1 |
| First Step Act (2018) | Pub. L. 115-391 | Federal sentencing reform, retroactive application |
| Mental Health Parity and Addiction Equity Act (2008) | Pub. L. 110-343 | Insurance parity for SUD treatment |
| ACA Essential Health Benefits (2010) | 42 U.S.C. Section 18022 | SUD treatment as essential health benefit |
| SUPPORT for Patients and Communities Act (2018) | Pub. L. 115-271 | Opioid crisis response, treatment access |
| Section 280E, Internal Revenue Code | 26 U.S.C. Section 280E | Prohibition on tax deductions for cannabis businesses |

### Key Court Cases

- *Leary v. United States*, 395 U.S. 6 (1969). Struck down the Marihuana Tax Act as unconstitutional, leading to the Controlled Substances Act.
- *Gonzales v. Raich*, 545 U.S. 1 (2005). Upheld federal authority to prohibit cannabis even in states with medical cannabis laws, under the Commerce Clause.
- *Harborside Health Center v. Commissioner*, T.C. Memo. 2018-93. Upheld application of Section 280E to cannabis businesses.
- *In re Purdue Pharma L.P.*, No. 23-124 (S. Ct. 2024). Supreme Court rejected initial Purdue Pharma bankruptcy plan that would have shielded the Sackler family from personal liability.

---

## Advocacy and Professional Organizations

### Drug Policy Reform

| Organization | Website | Focus |
|-------------|---------|-------|
| Drug Policy Alliance | drugpolicy.org | Comprehensive drug policy reform |
| NORML | norml.org | Cannabis legalization and decriminalization |
| Marijuana Policy Project | mpp.org | State and federal cannabis legalization |
| Students for Sensible Drug Policy | ssdp.org | Youth drug policy reform |
| Law Enforcement Action Partnership (LEAP) | lawenforcementactionpartnership.org | Law enforcement voices for reform |
| Harm Reduction Coalition | harmreduction.org | Harm reduction advocacy and services |
| National Harm Reduction Coalition | harmreduction.org | Technical assistance for harm reduction |

### Treatment and Recovery

| Organization | Website | Focus |
|-------------|---------|-------|
| American Society of Addiction Medicine (ASAM) | asam.org | Addiction medicine standards and advocacy |
| Faces & Voices of Recovery | facesandvoicesofrecovery.org | Recovery advocacy |
| Partnership to End Addiction | drugfree.org | Family support and prevention |
| National Alliance for Medication Assisted Recovery (NAMA) | methadone.org | MAT access and advocacy |
| Young People in Recovery | youngpeopleinrecovery.org | Youth recovery support |

### Civil Rights and Justice

| Organization | Website | Focus |
|-------------|---------|-------|
| ACLU | aclu.org | Racial justice in drug enforcement |
| The Sentencing Project | sentencingproject.org | Sentencing reform and racial disparities |
| Vera Institute of Justice | vera.org | Justice reform and incarceration reduction |
| Last Prisoner Project | lastprisonerproject.org | Cannabis prisoner release and expungement |

---

## Data Dashboards and Tools

| Tool | Provider | Description |
|------|----------|-------------|
| CDC Drug Overdose Data Dashboard | CDC | Interactive overdose death maps and trends |
| SAMHSA Behavioral Health Treatment Locator | SAMHSA | Find treatment facilities by location and services |
| DISA Cannabis Legality Map | DISA | Interactive map of state cannabis laws |
| Marijuana Policy Project State Policy Map | MPP | State-by-state cannabis policy tracker |
| Prison Policy Initiative Data Tools | PPI | Incarceration data and visualizations |
| USASpending.gov Drug Control | Treasury | Federal drug spending data |

---

## International Resources

| Resource | Organization | Description |
|----------|-------------|-------------|
| World Drug Report | UNODC | Annual global drug trends, trafficking, and policy |
| European Drug Report | EMCDDA | European drug trends, harm reduction data |
| Global Drug Policy Index | Harm Reduction International | Ranks countries on evidence-based drug policy |
| Transform Drug Policy Foundation Reports | Transform | International drug policy reform analysis |
| Global Commission on Drug Policy | Independent | High-level advocacy for drug policy reform |
| International Drug Policy Consortium (IDPC) | IDPC | Global network promoting evidence-based drug policy |

---

## Podcasts, Documentaries, and Media

### Podcasts

- *The Drug Policy Podcast* (Drug Policy Alliance). Weekly discussion of drug policy issues.
- *Crackdown* (Garth Mullins). Podcast produced by drug users about the overdose crisis and harm reduction.
- *Drugs and Stuff* (Drug Policy Alliance). Drug policy news and analysis.

### Documentaries

- *The House I Live In* (Eugene Jarecki, 2012). History and impact of the War on Drugs across communities.
- *Heroin(e)* (Elaine McMillion Sheldon, 2017). Oscar-nominated short about three women fighting the opioid crisis in Huntington, WV.
- *Crime + Punishment* (Stephen Maing, 2018). NYPD officers expose racial profiling and arrest quotas.
- *Dopesick* (Hulu, 2021). Limited series dramatizing the opioid crisis based on Beth Macy's book.
- *The Pharmacist* (Netflix, 2020). Documentary about a father investigating the opioid epidemic.

### Investigative Journalism

- *Pain Killer* (Barry Meier, New York Times). Early investigative reporting on OxyContin.
- *American Overdose* (Chris McGreal, The Guardian). Investigation of the opioid crisis origins.
- *The DEA's War on Doctors* (Radley Balko, Reason Magazine). Investigation of DEA overreach in medical practice.
- *60 Minutes / Washington Post: DEA Investigation* (2016). Revealed how legislation stripped DEA enforcement power over pharmaceutical distributors.

---

## Document Navigation

- Previous: [Roadmap](08-roadmap.md)
- Next: [Actions](10-actions.md)
- Up: [Drug Policy Overview](README.md)
